[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
The World in Medicine
August 14, 2002

Anthrax Inhibitors

Author Affiliations

Not Available

Not Available

JAMA. 2002;288(6):689. doi:10.1001/jama.288.6.689

Since the recent emergence of anthrax as a bioterrorist weapon, researchers have scrambled to learn more about the bacterium's deadly toxin and ways to disarm it. Now, researchers at the University of Padova in Italy and the Pasteur Institute in Paris have developed a test to screen for substances that inhibit lethal factor (LF)—an enzyme that is a key component of the toxin—and have created compounds that block LF's effects in cells.

After LF gains entry into macrophages and other cells, it specifically cleaves certain proteins involved in normal cell signaling and blocks signals that would normally summon other immune cells to fight the infection. The researchers created synthetic substrates for LF that are capable of detecting the activity of minute amounts of the enzyme. With these substrates in hand, scientists can quickly screen vast numbers of chemicals for their ability to inhibit LF's toxic effects.

First Page Preview View Large
First page PDF preview
First page PDF preview